Yunchao Huang

Afatinib versus cisplatin-based chemotherapy for EGFR mutation-positive lung adenocarcinoma (LUX-Lung 3 and LUX-Lung 6): analysis of overall survival data from two randomised, phase 3 trials

James Chih‐Hsin Yang, Yi‐Long Wu, Martin Schüler et al. · The Lancet Oncology · 2015 · 1.6K citations

Medicine, Oncology, Pharmacology +13

Camrelizumab plus carboplatin and pemetrexed versus chemotherapy alone in chemotherapy-naive patients with advanced non-squamous non-small-cell lung cancer (CameL): a randomised, open-label, multicentre, phase 3 trial

Caicun Zhou, Gongyan Chen, Yunchao Huang et al. · The Lancet Respiratory Medicine · 2020 · 505 citations

Medicine, Oncology, Pharmacology +13

Perioperative Toripalimab Plus Chemotherapy for Patients With Resectable Non–Small Cell Lung Cancer

Shun Lü, Wei Zhang, Lin Wu et al. · JAMA · 2024 · 336 citations · Full text

Medicine, Oncology, Pharmacotherapy +17

Clinical characteristics and medical service utilization of lung cancer in China, 2005–2014: Overall design and results from a multicenter retrospective epidemiologic survey

Jufang Shi, Le Wang, Ning Wu et al. · Lung Cancer · 2018 · 134 citations

Medicine, Oncology, Cancer Control +15

<scp>C</scp>hina national lung cancer screening guideline with low‐dose computed tomography (2015 version)

Qinghua Zhou, Ya‐guang Fan, Hong Bu et al. · Thoracic Cancer · 2015 · 89 citations · Full text

Medicine, Health Education, Preventive Medicine +17